Dr. Reddy's Launches Generic Requip XL
Requip XL is an orally administered, non-ergoline dopamine agonist indicated for the treatment of the signs and symptoms idiopathic Parkinson's disease. The precise mechanism of action of ropinirole as a treatment for Parkinson's disease is unknown, although it is believed to be due to stimulation of postsynaptic dopamine D2-type receptors within the caudate-putamen in the brain.
Ropinirole HCl XR will be available in 2mg, 4mg, 6mg strength tablets in 30- and 90-count bottles, and 8mg and 12mg strength tablets in 30-count bottles.
For more information call (908) 203-4933 or visit www.drreddys.com